TG Therapeutics to Host Conference Call on Fourth Quarter and Full Year 2025 Financial Results and Business Update [Yahoo! Finance]
TG Therapeutics to Host Conference Call on Fourth Quarter and Full Year 2025 Financial Results and Business Update
Long Term Data Published in JAMA Neurology Demonstrate Sustained Efficacy and Consistent Safety of BRIUMVI in Relapsing Multiple Sclerosis
TG Therapeutics (NASDAQ:TGTX) was downgraded by analysts at
Wall Street
TG Therapeutics Announces Collaboration with Christina Applegate to Raise Awareness of Multiple Sclerosis